Brief: Thyrocare Technologies Limited Approves Sale Of Entire Shareholding In Nueclear Healthcare
21/09/2026 10:29
BRIEF-Thyrocare Technologies Limited Approves Sale Of Entire Shareholding In Nueclear Healthcare Sept 21 (Reuters) - Thyrocare Technologies Limited THYO.NS:
THYROCARE TECHNOLOGIES LIMITED- APPROVES SALE OF ENTIRE SHAREHOLDING IN NUECLEAR HEALTHCARE
THYROCARE TECHNOLOGIES LIMITED- CONSIDERATION FOR SALE IS 1.41 BILLION RUPEES
THYROCARE TECHNOLOGIES - TO PURCHASE LAND AND BUILDINGS FROM NHL IN GURUGRAM AND HYDERABAD
THYROCARE TECHNOLOGIES - CONSIDERATION FOR PROPERTY PURCHASE FROM NHL IS 205.9 MILLION RUPEES
Source text: ID:nBSEbssqzM
Further company coverage: THYO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thyrocare Technologies
See all newsBrief: Thyrocare Technologies Limited Approves Sale Of Entire Shareholding In Nueclear Healthcare
India's Thyrocare hits record high after June-quarter profit rise
India's Thyrocare Technologies jumps to 5-month high after quarterly profit rise
Brief: Thyrocare Technologies Posts March-Qtr Consol Net Profit 471.2 Million Rupees
India's Thyrocare jumps on Phillip Capital initiation with 'Buy'